Biome in Medical Technology

Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership

...he-art technologies in chemistry, biology, automation, and information sciences in order to pursue new approaches towards the understanding of complex biomedical problems in cancer biology, immunology, neuroscience, and metabolic as well as infectious disease. These technologies cut across the life scien...

DNA Helps Reunite Children With Their Families

... Science Center The University of North Texas Health Science Center comprises the Texas College of Osteopathic Medicine, the Graduate School of biomedical Sciences, the School of Public Health, and the School of Health Professions. Key research areas include aging and Alzheimer's disease, cancer an...

CTMM Becomes One of the World's Largest Public-Private Partnerships in Translational Medical Research

...ld. This pivotal point in the organisation's development firmly positions the Netherlands as one of the world's leading destinations for translational biomedical research. "The 15 million euro allocated to this prostate cancer project, which brings the total allocated CTMM funding to 265 million eu...

Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimer's Disease

...and early-stage companies; connecting investors with their Investment Portfolio companies; expanding established life sciences ventures and relocating biomedical companies to Pennsylvania. www.plsg.com About Innovation Works (IW) Innovation Works provides risk capital and business e...

Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease

...rsity of Arizona. About National Institute of Aging The NIA leads the federal government effort conducting and supporting research on the biomedical, social and behavioral issues of older people. For more information on aging-related research and the NIA, go to www.nia.nih.gov . The NIA p...

Michael J. Fox Foundation Awards Over $2 Million for Validation of 10 Parkinson's Therapeutic Targets

...University of Brescia (Italy) Validation of Nurr1 as a Drug Target for the Treatment of PD Demetrios K. Vassilatis, PhD, Foundation for biomedical Research of the Academy of Athens, Greece About The Michael J. Fox Foundation Founded in 2000, The Michael J. Fox Foundation for...

Music & Medicine: Unique Collaboration Combines Performing Arts and Science

...ugh, to include a third. George Kondraske, PhD, professor of electrical and biomedical engineering at the University of Texas at Arlington and founding dire...mposed of the Texas College of Osteopathic Medicine, the Graduate School of biomedical Sciences, the School of Public Health, and the School of Health Profe...

University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test

...pany committed to providing the best genetic analysis products that translate the results of genomic science into solutions for molecular diagnostics, biomedical research, translational research and molecular medicine applications. As an industry innovator in DNA detection technology, SEQUENOM's MassARRAY...

USC Keck School of Medicine's Dr. Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL-2 Molecule Therapeutic

... clinical trials." "We are in the midst of a biomedical revolution. New technologies promise to resh...nia trains tomorrow's leaders in patient care and biomedical research and provides advanced health care t... Keck School of Medicine of USC is expanding its biomedical research enterprise and, in so doing, raisin...

UNT Health Science Center's Groundbreaking Research Applied to Protecting Brain After Traumatic Injury

...ence Center The University of North Texas Health Science Center comprises the Texas College of Osteopathic Medicine, the Graduate School of biomedical Sciences, the School of Public Health, and the School of Health Professions. Key research areas include aging and Alzheimer's disease, cancer an...

New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF

...n patients undergoing IVF: a randomized assessor-blind controlled trial. Human Reproduction 2006 Dec; 21(12):3217-27. 5. Platteau et al. Reprod biomed Online 2008; 17:190-8. ...

ADHD Genes Found; Known to Play Roles in Neurodevelopment

...eter S. White, Ph.D., a molecular geneticist and director of the Center for biomedical Informatics at Children's Hospital. "Instead, there may be hundreds o...sylvania School of Medicine ( Penn ). Xiaowu Gai, Ph.D., of the Center for biomedical Informatics at Children's Hospital, was a co-first author with Elia. ...

DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture (EDC) Clinical Trial Survey

...itively affect their decision to participate in trials. Other organizations participating in the 2009 survey include Data Management biomedical (DMB), Association for Clinical Data Management (ACDM), ARCS Australia Ltd and Der Fachverband fur Berufstatige in der Medizinischen Dokumentati...

CRi Oosight(TM) Instrument Crucial in IVF Breakthrough Demonstrating a Correlation Between Non-Invasive Egg Metrics and Pregnancy

...that can predict pregnancy outcome?" was published in March by Reproductive biomedicine Online. Cambridge Research & Instrumentation, Inc (CRi) is a biomedical imaging company providing innovative optical imaging solutions for ov...

UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients

... the U.S., Europe and Israel. StemEx has orphan drug designation in the U.S. and in Europe. Gamida Cell's current shareholders include: Elbit Imaging, biomedical Investment, Israel Healthcare Venture, Teva Pharmaceuticals, Amgen, Denali Ventures and Auriga Ventures. CONTACT: Courtney McCrimmo...

Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009

...is a great opportunity that allows us to present our company to the leading biomedical, health care and life science professionals from all over the world,"...dav Kidron, Oramed CEO. For more information about the upcoming ILSI biomed conference, please visit http://www2.kenes.com/biomed/Pages/Home.aspx ...

DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

...gy for the oral delivery of leuprolide for the treatment of prostate cancer and endometriosis. Through its Biodefense Division, DOR is developing biomedical countermeasures pursuant to the Project BioShield Act of 2004. DOR's biodefense products in development are recombinant subunit vaccines designe...

Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk

...ir overall health," said Steven R. Smith, M.D., Co-Principal Investigator and Professor and Assistant Director for Clinical Research at the Pennington biomedical Research Center. "Lorcaserin's positive impact on multiple secondary measures has important implications for improving co-morbidities associated...

PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)

...d chemical threats, today announced that it has submitted a proposal to the biomedical Advanced Research and Development Authority (BARDA) in response to a ...alortim(R) is well positioned for procurement consideration in the civilian biomedical stockpile. About Anthrax According to the Centers for Diseas...

Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Association's 69th Scientific Sessions

...al Treatment. Steven R. Smith, M.D., BLOOM Co-Principal Investigator and Professor and Assistant Director for Clinical Research at the Pennington biomedical Research Center; William R. Shanahan, M.D., Arena's Vice President and Chief Medical Officer; and Christen M. Anderson, M.D., Ph.D., Arena's Vic...

Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting

...cent accuracy in patients whose primary cancer was 'unknown' using traditional diagnostics - SAN DIEGO, June 1 /PRNewswire/ -- bioTheranostics, a biomerieux company that discovers, develops and commercializes new molecular diagnostic tests in oncology, announced that a recent study demonstrated the c...

Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients

...so Duenas-Gonzalez, M.D., Ph.D., Investigador de la Unidad de Investigacion biomedica en Cancer, Instituto Nacional de Cancerologia e Instituto de Investigaciones biomedicas in Mexico. "Lilly continues to look for ways to improve the su...

Cardiovascular Fitness Not Affected by Cancer Treatment

...hool of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the biomedical Graduate Research Organization (BGRO), home to 60 percent of the university's sponsored research funding. ...

Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009

...nd Prevention (CDC); The National Institute of Virology (NIV); The Battelle biomedical Research Center (BBRC); and The Southwest Foundation for biomedical Research (SFBR). Beyond therapeutic market opportunities, Aethlo...

Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research

... / Leader: Daniel A. Haber, M.D., Ph.D., Director of the Massachusetts General Hospital Cancer Center; Co-Leader: Mehmet Toner, Ph.D., Professor of biomedical Engineering, Harvard Medical School ; and "Cutting off the Fuel Supply: A New Approach to the Treatment of Pancreatic Cancer" / Lea...

Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting

...r belief that we have created a sophisticated solution for the treatment of focal articular cartilage defects by providing a device with the requisite biomechanical and biological properties for promoting osteochondral repair," he concluded. The CRD is a composite of several resorbable biomaterials, ...

PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA

...n doses of a next generation rPA anthrax vaccine for the country's civilian biomedical stockpile. In September 2008, PharmAthene received notificatio... Institute of Allergy and Infectious Disease (NIAID) and transferred to the biomedical Advanced Research and Development Authority (BARDA) in April 2009. W...

Getting More From Whole-Transcript Microarrays

....0 ST platforms are available, or any other whole-transcript microarray design. The Walter and Eliza Hall Institute is one of the world's leading biomedical research centres. Established in 1915 and affiliated with The University of Melbourne and The Royal Melbourne Hospital, the Institute's missio...

Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)

...ne for our Company." Raxibacumab is a first-in-class treatment for anthrax, and is being developed under a contract entered into in 2006 with the biomedical Advanced Research and Development Authority (BARDA) of the Office of the Assistant Secretary for Preparedness and Response (ASPR), U.S. Departme...

Myelin Removal Beads: Premium Efficiency for Neural Cell Separations and Antibody Stainings

... one of the largest and most successful biotechnology companies in Germany. More than 1,100 employees worldwide develop, produce and sell products for biomedical research and clinical applications. The renowned MACS Technology for magnetic separation of cells has become a standard technology in research l...

TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics

...emistry, contract research services and ISO/QSR compliant cGMP production facilities are offered. TriLink's solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 90 scientists and other pr...

Corgenix, Tulane Announce Award of NIH Grant Extending Hemorrhagic Fever Virus Product Development Program

...ne and public health and tropical medicine. About Autoimmune Technologies, LLC Autoimmune Technologies (New Orleans, La.) is a privately held biomedical company. It has licensed several breakthrough research discoveries from Tulane University School of Medicine and has made exciting discoveries...

Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity

...1 Treatment," will be presented at the Hot Topic poster session by Donna H. Ryan, M.D., Associate Executive Director for Clinical Research, Pennington biomedical Research Center in Baton Rouge, LA. The presentation marks the first time these results have been shared with the medical community at a major m...

TriLink Launches CleanAmp(TM) dNTPs for Hot Start PCR

...tract research services and GMP production facilities for oligos and small molecules are offered. TriLink's solutions help advance drug discovery and biomedical research. For more information visit www.trilinkbiotech.com or contact: TriLink BioTechnologies, Inc. Shawna Leaver, 858-546-...

BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available

...s, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 43,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include as...

Arrayit to Mass Produce Rapid H1N1 Swine Flu Test Chip

...hat may result from changes in the Company's business operations; our ability to keep pace with technological advances; significant competition in the biomedical business; our relationships with key suppliers and customers; quality and consumer acceptance of newly introduced products; market volatility; n...

Elusys' Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study

... contract #HHSN272200700035 from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the biomedical Advanced Research and Development Authority (BARDA), part of the Department of Health and Human Services. In April of 2007, Anthim was selected...

New Study Suggests Rx Estrogen Delivery Through the Skin May Show Safety Benefits as Opposed to Oral Delivery

...out NYU Langone Medical Center Located in the heart of New York City, NYU Langone Medical Center is a premier center for health care, biomedical research, and medical education. For over 167 years, NYU physicians and researchers have contributed to the practice and science of medicine....

DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation

...gy for the oral delivery of leuprolide for the treatment of prostate cancer and endometriosis. Through its Biodefense Division, DOR is developing biomedical countermeasures pursuant to the Project BioShield Act of 2004. DOR's biodefense products in development are recombinant subunit vaccines designe...

Astrocytes Help Separate Man From Mouse

...y-owned teaching hospital. As upstate New York's premier health care delivery network, patients benefit from the Medical Center's robust teaching and biomedical research programs. ...